COMPOSITIONS AND METHODS FOR NEUROLOGICAL DISEASES
申请人:Coda Biotherapeutics, Inc.
公开号:US20190161529A1
公开(公告)日:2019-05-30
Compositions and methods are provided for modulating the activity of cells using engineered receptors, polynucleotide encoded engineered receptors, and gene therapy vectors comprising polynucleotides encoding engineered receptors. These compositions and methods find particular use in modulating the activity of neurons, for example in the treatment of disease or in the study of neuronal circuits.
Mild Negishi Cross-Coupling Reactions Catalyzed by Acenaphthoimidazolylidene Palladium Complexes at Low Catalyst Loadings
作者:Zelong Liu、Ningning Dong、Mizhi Xu、Zheming Sun、Tao Tu
DOI:10.1021/jo400803s
日期:2013.8.2
3a exhibited extremely high catalytic activity toward Negishicross-coupling of alkylzinc reagents with a wide range of (hetero)arylhalides under mild reaction conditions within 30 min. Besides a great number of bromoarenes, various less expensive and inactive (hetero)aryl chlorides were coupled successfully with the alkyl- and arylzincreagents, in which active functional groups (such as -NH2) were
考虑到衍生自π-延伸的咪唑鎓盐的亚烷基的强大的σ-供体性质有利于提高所得钯N-杂环卡宾配合物的催化活性,因此制备了具有健壮的并咪唑-亚烷基钯配合物3a - c,具有不同的大取代基团通过在纯净的3-氯吡啶中与PdCl 2和K 2 CO 3加热,从相应的啶咪唑氯化物中得到满意的收率。即使在催化剂负载量低至0.25 mol%的情况下,配合物3a在温和的反应条件下,在30分钟内显示出对烷基锌试剂与各种(杂)芳基卤化物的Negishi交叉偶联极高的催化活性。除了大量的溴代芳烃外,还成功地将各种较便宜且不活泼的(杂)芳基氯化物与烷基-和芳基锌试剂偶联,其中具有活性官能团(例如-NH 2))即使在无保护的一锅双偶转换中也具有良好的耐受性。此外,在与仲烷基锌试剂偶联的情况下,有效抑制了导致异构化的线性产物的不希望的β-氢化物消除。通过杂芳基锌试剂和杂环氯代芳烃的偶联,该催化剂体系还显示出在杂二芳基结构方面